Zimmer Biomet Holdings, Inc.: director Robert Hagemann received 306.066 shares

What happened

• Robert Hagemann, director, received 306.066 phantom stock units (derivative) as a grant/award on Sep 30, 2026 at a price of $0.00, total value $0.00.

Key details

• Transaction date and price: Sep 30, 2026 at $0.00 per unit (transaction code A, derivative).
• Filing date: Oct 2, 2026; the filing does not indicate it was late.
• Shares owned after the transaction: not reported in the filing.
• Footnotes from the filing:
  • F1: Units accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
  • F2: Conversion/exercise price is 1-for-1.
  • F3: Units to be settled in cash in 5 annual installments commencing within 60 days after the end of the calendar year in which cessation of service as a director occurs.
  • F4: Includes 85.331 phantom stock units accrued on Jul 31, 2026 under the dividend reinvestment provision of the Deferred Compensation Plan for Non-Employee Directors.

Why it may matter

• This filing reports a derivative grant of phantom stock units under a deferred compensation plan; the units are to be settled in cash per the plan terms.
• The filing does not show why the insider traded or why the company acted.